FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379933411> ?p ?o ?g. }

• W4379933411 endingPage "100122" @default.
• W4379933411 startingPage "100122" @default.
• W4379933411 abstract "Five studies (two dose determination, two dose confirmation, and one speed of flea kill study) were conducted to assess the immediate (therapeutic) efficacy and long-term persistent (preventive) efficacy of a single spot-on application containing the novel acaricide and insecticide tigolaner in combination with emodepside and praziquantel (Felpreva®, Vetoquinol S.A. Lure, France) applied to cats artificially infested with Ctenocephalides felis. Eight cats per group were randomly allocated to 0, 1×, 1.3× and 2× of the minimum dose (14.5 ​mg/kg body weight) of tigolaner (dose determination studies) or randomly allocated to 0 and 1× of the dosage (dose confirmation studies). Onset of efficacy was assessed in a speed of flea kill study on an existing flea infestation 8, 12 and 24 ​h after treatment and reassessed after monthly flea reinfestation until 13 weeks post-treatment. Efficacy was calculated according to the Abbott formula using arithmetic means. Efficacy was claimed when (i) control groups were adequately infested (flea retention ≥ 50%) at each time-point in the studies; (ii) flea counts in treated groups were significantly lower (P ​≤ ​0.05) than flea counts in control groups; and (iii) calculated efficacy was ≥ 90% (speed of flea kill study) and ≥ 95% (dose determination and dose confirmation studies). Tigolaner at 14.5 ​mg/kg body weight was 100% effective against fleas on Day 1 (immediate, therapeutic efficacy) in both, dose determination and dose confirmation studies. The long-term persistent efficacy in week 13 ranged between 96.3% and 100%. Fleas were rapidly killed within 12 ​h after treatment (100% flea reduction, immediate efficacy). New flea infestations were successfully prevented for 8 weeks (98.9–100% flea reduction) within 8 ​h after reinfestation, and at week 13 (96.3% flea reduction) within 24 ​h after reinfestation." @default.
• W4379933411 created "2023-06-09" @default.
• W4379933411 creator A5002702042 @default.
• W4379933411 creator A5013544516 @default.
• W4379933411 creator A5022618610 @default.
• W4379933411 creator A5037052416 @default.
• W4379933411 creator A5041739368 @default.
• W4379933411 creator A5061656274 @default.
• W4379933411 creator A5065831762 @default.
• W4379933411 creator A5070249346 @default.
• W4379933411 creator A5081221018 @default.
• W4379933411 date "2023-01-01" @default.
• W4379933411 modified "2023-10-16" @default.
• W4379933411 title "Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea Ctenocephalides felis" @default.
• W4379933411 cites W1577393878 @default.
• W4379933411 cites W1614161003 @default.
• W4379933411 cites W1841369928 @default.
• W4379933411 cites W1981225398 @default.
• W4379933411 cites W1998673982 @default.
• W4379933411 cites W2002907311 @default.
• W4379933411 cites W2015511980 @default.
• W4379933411 cites W2022949333 @default.
• W4379933411 cites W2050931636 @default.
• W4379933411 cites W2068939833 @default.
• W4379933411 cites W2078938753 @default.
• W4379933411 cites W2081301587 @default.
• W4379933411 cites W2089738259 @default.
• W4379933411 cites W2095540646 @default.
• W4379933411 cites W2098608189 @default.
• W4379933411 cites W2110202393 @default.
• W4379933411 cites W2110893280 @default.
• W4379933411 cites W2121773591 @default.
• W4379933411 cites W2123036062 @default.
• W4379933411 cites W2133294760 @default.
• W4379933411 cites W2178448382 @default.
• W4379933411 cites W2605056555 @default.
• W4379933411 cites W2765570266 @default.
• W4379933411 cites W2781567040 @default.
• W4379933411 cites W2871838339 @default.
• W4379933411 cites W2947723834 @default.
• W4379933411 cites W2991346364 @default.
• W4379933411 cites W3091632576 @default.
• W4379933411 cites W3096497431 @default.
• W4379933411 cites W3141260100 @default.
• W4379933411 cites W3148266884 @default.
• W4379933411 cites W3200109621 @default.
• W4379933411 cites W4253550892 @default.
• W4379933411 cites W4292685876 @default.
• W4379933411 cites W4379276572 @default.
• W4379933411 doi "https://doi.org/10.1016/j.crpvbd.2023.100122" @default.
• W4379933411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37441539" @default.
• W4379933411 hasPublicationYear "2023" @default.
• W4379933411 type Work @default.
• W4379933411 citedByCount "2" @default.
• W4379933411 countsByYear W43799334112023 @default.
• W4379933411 crossrefType "journal-article" @default.
• W4379933411 hasAuthorship W4379933411A5002702042 @default.
• W4379933411 hasAuthorship W4379933411A5013544516 @default.
• W4379933411 hasAuthorship W4379933411A5022618610 @default.
• W4379933411 hasAuthorship W4379933411A5037052416 @default.
• W4379933411 hasAuthorship W4379933411A5041739368 @default.
• W4379933411 hasAuthorship W4379933411A5061656274 @default.
• W4379933411 hasAuthorship W4379933411A5065831762 @default.
• W4379933411 hasAuthorship W4379933411A5070249346 @default.
• W4379933411 hasAuthorship W4379933411A5081221018 @default.
• W4379933411 hasBestOaLocation W43799334111 @default.
• W4379933411 hasConcept C126322002 @default.
• W4379933411 hasConcept C126838900 @default.
• W4379933411 hasConcept C140793950 @default.
• W4379933411 hasConcept C149857219 @default.
• W4379933411 hasConcept C165901193 @default.
• W4379933411 hasConcept C203014093 @default.
• W4379933411 hasConcept C2776225656 @default.
• W4379933411 hasConcept C2776347271 @default.
• W4379933411 hasConcept C2777056448 @default.
• W4379933411 hasConcept C2777786777 @default.
• W4379933411 hasConcept C2779254346 @default.
• W4379933411 hasConcept C2779744950 @default.
• W4379933411 hasConcept C2779904517 @default.
• W4379933411 hasConcept C3019361228 @default.
• W4379933411 hasConcept C33070731 @default.
• W4379933411 hasConcept C42972112 @default.
• W4379933411 hasConcept C71924100 @default.
• W4379933411 hasConcept C74714110 @default.
• W4379933411 hasConcept C86803240 @default.
• W4379933411 hasConcept C98274493 @default.
• W4379933411 hasConceptScore W4379933411C126322002 @default.
• W4379933411 hasConceptScore W4379933411C126838900 @default.
• W4379933411 hasConceptScore W4379933411C140793950 @default.
• W4379933411 hasConceptScore W4379933411C149857219 @default.
• W4379933411 hasConceptScore W4379933411C165901193 @default.
• W4379933411 hasConceptScore W4379933411C203014093 @default.
• W4379933411 hasConceptScore W4379933411C2776225656 @default.
• W4379933411 hasConceptScore W4379933411C2776347271 @default.
• W4379933411 hasConceptScore W4379933411C2777056448 @default.
• W4379933411 hasConceptScore W4379933411C2777786777 @default.
• W4379933411 hasConceptScore W4379933411C2779254346 @default.
• W4379933411 hasConceptScore W4379933411C2779744950 @default.

• next